Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
95,251,857
-
Share change
-
-4,752,207
-
Total reported value
-
$682,942,286
-
Put/Call ratio
-
62%
-
Price per share
-
$7.17
-
Number of holders
-
113
-
Value change
-
-$98,037,351
-
Number of buys
-
61
-
Number of sells
-
83
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2019
As of 30 Jun 2019,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,251,857 shares.
The largest 10 holders included
Fosun International Ltd, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., Point72 Asset Management, L.P., Neuberger Berman Group LLC, STATE STREET CORP, and NORGES BANK.
This page lists
113
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.